Khezrian, MinaMcNeil, Christopher J.Murray, Alison D.Myint, Phyo K.2020-06-162020-06-162020Khezrian, M, McNeil, C J, Murray, A D & Myint, P K 2020, 'An overview of prevalence, determinants and health outcomes of polypharmacy', Therapeutic Advances in Drug Safety, vol. 11, pp. 1-10. https://doi.org/10.1177/20420986209337412042-0986PubMedCentral: PMC7294476ORCID: /0000-0003-4915-4847/work/76976618SCOPUS: 85086331803ORCID: /0000-0003-3852-6158/work/163198636https://hdl.handle.net/2164/1450710454662enghealth outcomemultimorbidityolder adultspolypharmacyMORTALITYDRUG-USEADULTSRISKDWELLING OLDER MENFRAILTYCLINICAL CONSEQUENCESCAREANTICHOLINERGIC BURDENEPIDEMIOLOGYR Medicine (General)Pharmacology (medical)R1Journal article10.1177/2042098620933741http://www.scopus.com/inward/record.url?scp=85086331803&partnerID=8YFLogxK11